Nursing care
Taxanes nursing considerations: infusion reactions, neutropenia and neuropathy
Written and reviewed by Nicole Ramirez, BSN, RN, CMSRN · 4 min read · Updated November 2026
Short answer
Nursing considerations for taxanes such as paclitaxel and docetaxel focus on three risks: a hypersensitivity reaction during the infusion, low neutrophil counts that peak about a week and a half later, and numbness or tingling in the hands and feet. Premedication is given before each dose, and the nurse stays close in the first minutes.
How taxanes work and why the side effects follow
MedlinePlus describes paclitaxel as an antimicrotubule agent. Taxanes lock the internal scaffolding that a cell needs to divide, so fast-dividing cells stall. Cancer cells are the target, but bone marrow and hair follicles divide quickly too, which explains low white cell counts and hair loss. Nerves depend on the same microtubules to move material along long axons, which is the basis for neuropathy.
The two drugs nursing students meet most are paclitaxel and docetaxel. They share the class risks, but each has a feature worth knowing by name: paclitaxel for infusion hypersensitivity and slow heart rate, docetaxel for fluid retention and nail changes. Albumin-bound paclitaxel is a separate product with its own label.
Infusion reactions: the first minutes matter most
The paclitaxel label carries a boxed warning: severe reactions, with shortness of breath, low blood pressure, swelling of the face or throat, and widespread hives, occurred in 2 to 4 percent of trial patients, and some were fatal despite premedication. Every patient is pretreated with a corticosteroid, diphenhydramine and an H2 blocker. A patient who has had a severe reaction is not rechallenged with the drug.
So the nurse confirms premedication was given, takes baseline vital signs, and watches the client closely early in the infusion. At the first sign of flushing, chest tightness or wheeze, stop the infusion, keep the line open, stay with the client and call for help under the reaction protocol. Slowing the drip and waiting to see is the wrong move; the reaction can progress quickly. Docetaxel also carries a warning for severe allergic reactions and uses corticosteroid premedication.
Neutropenia, heart rhythm and fluid
Neutropenia is the dose-limiting effect. The paclitaxel label says not to give it when the baseline neutrophil count is below 1,500 cells/mm3, notes a median nadir around day 11, and calls for frequent blood counts. Check the count before the infusion starts and report a low value rather than hanging the bag. MedlinePlus tells patients to seek care for a fever over 100.4 F.
Severe conduction problems are uncommon with paclitaxel, under 1 percent in the label, but a slow or irregular pulse during the infusion is reported, and the label advises continuous cardiac monitoring for later doses after a significant event. For docetaxel, MedlinePlus lists serious fluid retention and liver problems among its main warnings. Daily weights and checks for ankle swelling and breathlessness belong in the plan.
Peripheral neuropathy and the alcohol in the bag
Numbness, tingling or burning in the hands and feet appears on the MedlinePlus side effect lists for both drugs. Ask about buttons, writing, dropping objects and balance at every visit, not only whether the client feels tingling. Worsening function is reported because it may change the treatment plan. Safety teaching covers checking feet, testing bath water and clearing tripping hazards.
Some docetaxel preparations contain alcohol. MedlinePlus warns that clients may feel its effects during or for a couple of hours after the infusion and should not drive until they know how it affects them. This matters for a client who avoids alcohol, has liver disease, or plans to drive home alone. Fetal harm is listed for both drugs, so pregnancy prevention is part of teaching.
Hypothetical scenario: three findings, one first action
Hypothetical scenario, not a real exam item: ten minutes into a first paclitaxel infusion, the client says her face feels hot and her chest feels tight. Her pressure has fallen from 128/76 to 96/58. Earlier she mentioned tingling fingers from a previous drug, and her morning neutrophil count was within the range set for treatment.
Stopping the infusion is first. Flushing, chest tightness and a falling pressure in the opening minutes point to hypersensitivity, which can be fatal. Documenting the tingling is real but can wait. Giving an extra dose of diphenhydramine and restarting slowly is wrong because it treats the reaction as minor and keeps the drug running.
Sources and further reading
Pfizer prescribing information: Paclitaxel injection warnings. Boxed hypersensitivity warning and 2 to 4 percent incidence, triple premedication, no rechallenge, neutrophil threshold of 1,500 cells/mm3, nadir near day 11, conduction abnormalities and fetal risk.
MedlinePlus: Paclitaxel (with polyoxyethylated castor oil) Injection. Antimicrotubule class, neuropathy, joint and muscle pain, mouth sores, slow or irregular heartbeat and fever over 100.4 F to report.
MedlinePlus: Docetaxel Injection. Warnings for neutropenia, liver problems, allergic reactions and fluid retention; corticosteroid premedication; alcohol content and driving; nail changes and neuropathy.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
What are the nursing considerations for taxanes?
Confirm premedication, check the neutrophil count before the infusion, watch closely for a reaction early on, monitor pulse and blood pressure, track neuropathy at each visit, and for docetaxel monitor weight and edema. Follow chemotherapy safe-handling rules throughout.
What side effects should the nurse monitor with taxanes?
Hypersensitivity during the infusion, neutropenia with infection risk, numbness or tingling in hands and feet, joint and muscle pain, mouth sores, hair loss, slow or irregular heartbeat, and with docetaxel, fluid retention, nail changes and liver problems.
What should clients be taught about taxanes?
Check temperature often and report fever over 100.4 F, avoid sick contacts, report numbness that affects daily tasks, protect the feet, report swelling or breathlessness, avoid pregnancy, and do not drive after a docetaxel infusion until its alcohol effect is known.
More on pharmacology
Guides on this